P-glycoprotein (P-gp)-mediated multidrug resistance (MDR) is a major obstacle in achieving the therapeutic benefits of paclitaxel (PTX) in the treatment of huma
Glomerular endothelial cell (GEC) injury plays an important role in the early stage of diabetic nephropathy (DN).Previous studies show that a PKCβ inhibitor is
Breast cancer is the most vicious killer for women,and tumor metastasis is one of the leading causes of breast cancer therapy failure.In this study,a new pH-sen
Sorafenib is an oral multikinase inhibitor that suppresses tumor cell proliferation and angiogenesis and promotes tumor cell apoptosis.It was approved by the FD